Management of drooling in children

Archives of Disease in Childhood: Education and Practice Edition

Volumn 96, Issue 1, 2011, Pages 25-30

  Fairhurst, C B R ^a   Cockerill, H ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZATROPINE; BOTULINUM TOXIN A; BROFLEX; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOBAZAM; CLONAZEPAM; GLYCOPYRRONIUM BROMIDE; IPRATROPIUM BROMIDE; METHYLPHENIDATE; NEUROLEPTIC AGENT; SCOPOLAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

ACUPUNCTURE; ANXIETY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLURRED VISION; CHILD; CLINICAL ASSESSMENT; CONSERVATIVE TREATMENT; CONSTIPATION; DEPRESSION; DEVICE THERAPY; DROOLING RATING SCALE; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; DRY EYE; DYSKINESIA; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; HOMEOPATHY; HUMAN; HYPERSALIVATION; IRRITABILITY; MUSCLE EXERCISE; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; RATING SCALE; RECOMMENDED DRUG DOSE; SALIVATION; SEDATION; SEIZURE; SIDE EFFECT; SKIN ALLERGY; SYMPATHETIC INNERVATION; SYSTEMATIC REVIEW (TOPIC); TACHYCARDIA; URINE RETENTION; VISUAL DISORDER; XEROSTOMIA;

CHILD; CHILD, PRESCHOOL; HUMANS; SIALORRHEA;

EID: 78751506386     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2007.129478     Document Type: Article

References (41)

1. Blasco PA. Management of drooling: 10 years after the Consortium on Drooling, 1990. Dev Med Child Neurol 2002;44:778-81.
2. Van de Heyning PH, Marquet JF, Creten WL. Drooling in children with cerebral palsy. Acta Otorhinolaryngol Belg 1980;34:691-705.
3. Erasmus CE, Van Hulst K, Rotteveel LJ, et al. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Dev Med Child Neurol 2009;51:454-9.
4. Hockstein NG, Samadi DS, Gendron K, et al. Sialorrhea: a management challenge. Am Fam Physician 2004;69:2628-34.
5. Hussein I, Kershaw AE, Tahmassebi JF, et al. The management of drooling in children and patients with mental and physical disabilities: a literature review. Int J Paediatr Dent 1998;8:3-11.
6. Tahmassebi J F, Curzon ME. Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol 2003;45:613-7.
7. van der Burg JJ, Jongerius PH, van Limbeek J, et al. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling. Eur J Pediatr 2006;165:37-41.
8. Reddihough D, Johnson H, Ferguson E. The role of a saliva control clinic in the management of drooling. J Paediatr Child Health 1992;28:395-7.
9. Walker PJ, Hutchinson M, Cant J, et al. Chronic drooling: a multidisciplinary approach to assessment and management. Aust J Otolaryng 1994;1:542-5.
10. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988;3:73-8.
11. Wong V, Sun JG, Wong W. Traditional Chinese Medicine (tongue acupuncture) in children with drooling problems. Pediatr Neurol 2001;25:47-54.
12. Orr C. Mouth madness, oral motor activities for children. San Antonio: Therapy Skill Builders, 1998.
13. Domaracki LS, Sisson LA. Decreasing drooling with oral motor stimulation in children with multiple disabilities. Am J Occup Ther 1990;44:680-4.
14. Inga CJ, Reddy AK, Richardson SA, et al. Appliance for chronic drooling in cerebral palsy patients. Pediatr Dent 2001;23:241-2.
15. Jongerius PH, van Tiel P, van Limbeek J, et al. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling. Arch Dis Child 2003;88:911-4.
16. Lewis DW, Fontana C, Mehallick LK, et al. Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 1994;36:484-6.
17. Meyer-Heim AD, Fairhurst C, Khan Y. Transdermal Scopolamine induced seizures in adolescents with cerebral palsy and epilepsy. Dev Med Child Neurol 2004;46:22.
18. Firth AY, Walker K. Visual side-effects from transdermal scopolamine (hyoscine). Dev Med Child Neurol 2006;48:137-8.
19. Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996;150:932-5.
20. Mier RJ, Bachrach SJ, Lakin RC, et al. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000;154:1214-8.
21. Reddihough D, Johnson H, Staples M, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol 1990;32:985-9.
22. Surtees R. Key-note presentation at annual conference of British Academy of Childhood Disability; April 2006.
23. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, et al. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 1989;31:309-19.
24. Chou KL, Evatt M, Hinson V, et al. Sialorrhea in Parkinson's disease: a review. Mov Disord 2007;22:2306-13.
25. Porta M, Gamba M, Bertacchi G, et al. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatr 2001;70:538-40.
26. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73-81.
27. Bothwell JE, Clarke K, Dooley JM, et al. Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol 2002;27:18-22.
28. Jongerius PH, Joosten F, Hoogen FJ, et al. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 2003;113:107-11.
29. Lipp A, Trottenberg T, Schink T, et al. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003;61:1279-81.
30. Jongerius PH, van den Hoogen FJ, van Limbeek J, et al. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 2004;114:620-7.
31. Banerjee KJ, Glasson C, O'Flaherty SJ. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol 2006;48:883-7.
32. Benson J, Daugherty KK. Botulinum toxin A in the treatment of sialorrhea. Ann Pharmacother 2007;41:79-85.
33. Reid SM, Johnstone BR, Westbury C, et al. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Dev Med Child Neurol 2008;50:123-8.
34. Ong LC, Wong SW, Hamid HA. Treatment of drooling in children with cerebral palsy using ultrasound guided intraglandular injections of Botulinum Toxin A. J Pediatr Neurol 2009;7:141-5.
35. Heinen F, Molenaers G, Fairhurst C, et al. European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 2006;10:215-25.
36. Koischwitz D, Gritzmann N. Ultrasound of the neck. Radiol Clin North Am 2000;38:1029-45.
37. Burton MJ. The surgical management of drooling. Dev Med Child Neurol 1991;33: 1110 - 6.
38. Webb K, Reddihough DS, Johnson H, et al. Long-term outcome of saliva-control surgery. Dev Med Child Neurol 1995;37:755-62.
39. Crysdale WS, Raveh E, McCann C, et al. Management of drooling in individuals with neurodisability: a surgical experience. Dev Med Child Neurol 2001;43:379-83.
40. Syeda F, Ahsan F, Nunez DA. Quality of life outcome analysis in patients undergoing submandibular duct repositioning surgery for sialorrhoea. J Laryngol Otol 2007;121:555-8.
41. Martin TJ, Conley SF. Long-term efficacy of intra-oral surgery for sialorrhea. Otolaryngol Head Neck Surg 2007;137:54-8.